. . . . . . . "[Intravenous injections of nmMLCK silencing RNA, either directly or as cargo within angiotensin-converting enzyme (ACE) antibody-conjugated liposomes (to target the pulmonary vasculature selectively), decreased nmMLCK lung expression (?70% reduction) and significantly attenuated LPS-induced and VILI-induced lung inflammation (?40% reduction in bronchoalveolar lavage protein).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:11:58+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .